Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 1256    

   Table of Contents      
Year : 2012  |  Volume : 135  |  Issue : 1  |  Page : 3-5

Elimination of leprosy & possibility of eradication - the Indian scenario

Former Director, National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR) Taj Ganj, Agra 282 001, India

Date of Web Publication1-Mar-2012

Correspondence Address:
K V Desikan
C/o Dr Prabha Desikan, Department of Microbiology, Bhopal Memorial Hospital & Research Centre, Raisen Bypass Road, Karond, Bhopal 462 038
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0971-5916.93415

Rights and Permissions

How to cite this article:
Desikan K V. Elimination of leprosy & possibility of eradication - the Indian scenario. Indian J Med Res 2012;135:3-5

How to cite this URL:
Desikan K V. Elimination of leprosy & possibility of eradication - the Indian scenario. Indian J Med Res [serial online] 2012 [cited 2021 Sep 29];135:3-5. Available from:

Over several centuries, leprosy had remained a dreaded, incurable disease. Patients were viewed with abhorrence, ostracized and subjected to inhuman treatment. Today, the stigma and prejudice against leprosy have reduced considerably, and the ravages of the disease are rarely seen in the community. This has been possible due the availability of effective drugs to cure the disease, access to technology for early diagnosis, prevention and repair of deformities, as well as increased awareness in society about leprosy. At a public health level, this has led to effective control of transmission and spread of disease. We have successfully achieved elimination, and are now moving towards eradication of leprosy.

The first attempt to deal with leprosy as a public health problem was taken up in 1952 by the Gandhi Memorial Leprosy Foundation (GMLF), an institution started under the Gandhi Memorial Trust. At that time, the only method to deal with the disease was to isolate leprosy patients in Leprosy "Homes" or "Asylums". Such places were very few and inadequate. Dapsone was a new drug that had just been introduced. A field study was piloted at GMLF which envisaged identification of all leprosy patients in a fixed geographic area, followed by domiciliary treatment with dapsone. Rigorous health education was carried out to explain the true facts about leprosy. For the first time in a leprosy campaign, a house to house survey was carried out, and every man, woman and child was examined for signs of leprosy. That was the beginning of the SET (Survey, Education and Treatment) programme of GMLF. The work first started in Sewagram (Wardha) in 1952, was subsequently replicated in 12 other centres of GMLF in different States. It soon became obvious that the SET programme, initiated by GMLF, was scientific, practical and a very effective method for control of the disease and the Government of India took it up. The National Leprosy Control Programme (NLCP) was started in 1955 and the SET method became the standard procedure for leprosy control in the entire country. Later, the WHO also endorsed the method, and it was adopted the world over.

The NLCP (which was later converted to National Leprosy Eradication Programme, NLEP) was able to achieve astounding success through careful planning and systematic work. The NLCP was included in the First Five Year Plan in 1955, and leprosy control work started in full swing. The first Government Leprosy Control Unit was established in 1958 at Hiramandalam in Srikakulam district of Andhra Pradesh. The subsequent Five Year Plans covered the entire country district by district. The pattern that was followed involved the setting up of Leprosy Control Units (LCU) and SET centres in each district starting from 1955. An LCU covered a population of one lakh, with a full time medical officer and 10 paramedical workers (PMW). An SET centre covered a population of 15000 with one PMW supervised by one part time medical officer. The Government and some NGOs set up a large number of training centres, where PMWs and doctors were trained. The Government and the NGOs co-operated to establish a large number of LCUs, and by 1970, the entire country was covered.

No data were available regarding the prevalence of leprosy prior to 1955. With the progress of NLEP, leprosy prevalence became clear and by mid-seventies, extensive data were collected. By 1980, a total of 40 lakh cases were recorded, giving a prevalence rate of 58 per 10,000 population. In 1982, there was a major advance in the treatment of leprosy. In 2005, the Government took another major step towards expansion of the NLEP. Leprosy work, which had been carried out so far as a vertical programme, was integrated into the general health services. There were no more special leprosy clinics. All hospitals, dispensaries and PHCs had to treat leprosy patients. Further, the field staff of PHCs had to take up case finding and follow up along with their regular duties. Multidrug therapy was introduced in 1982 with rifampicin, clofazimine and dapsone. This regimen was adopted throughout the country with remarkable success [1] . A very rapid and steep fall in prevalence of the disease was seen. The fall was so spectacular that by 2005, the prevalence came down to less than 1/10000. A prevalence less than 1/10000 indicates a state of "elimination" of the disease, when the disease ceases to be a public health problem. This was indeed a landmark achievement. By the end of 2010, the prevalence came down to 0.69/10000 2 . In this context, it must be pointed out that cases of leprosy are not uniformly distributed but tend to cluster in certain localities, villages or taluks. Hence, while the country as whole has eliminated leprosy, two States, Bihar and Chattisgharh are yet to achieve elimination (with a prevalence rate of 1.12 and 1.94, respectively). Of the total of 640 districts, 110 districts still have prevalence rates between 1 and 2/10000, while in 530 districts, elimination has been achieved [2] .

While there have been remarkable achievements in several aspects of leprosy control within a span of just 4 to 5 decades, these need to be put into perspective in relation to the possibility of eradicating the disease and prevention of resurgence [3] . The most striking achievement of the Programme remains the reduction of prevalence to elimination level. However, in my experience there have been instances where some over-enthusiastic workers have not registered many new cases in order to keep the prevalence rates low. It is imperative that severe steps be taken to prevent such misdemeanors.

As mentioned above, it has been possible to bring down the Prevalence Rate to as low a level as 0.6/10000. However, an overall reduction in number of cases can cause problems like: (i) Reduction of political commitment, policy support and allocation of resources; (ii) Decline in capacity to diagnose and treat cases of leprosy [4] . In fact, an increase in the incidence of leprosy has already been reported in one district due to the above causes [5] .

Although elimination of leprosy has been achieved, new cases will continue to occur for some more years. Constant vigilance is required to see that the disease does not reappear in the community. It is seen that initially the Annual New Case Detection Rate (ANCDR) showed a significant fall [1] . However, subsequent to 2005, it has more or less remained at the same level. This is a warning sign, and an indication that there should be an active thrust to identify new cases. It is important to identify any hidden infective source cases, trace and treat. A national sample survey was recently carried out to find out any difference in the known and actual cases (Katoch K, 2011, personal communication). Such surveys should be repeated.

Integration of leprosy into the general health service has greatly enhanced the scope of leprosy service. By integration, discrimination against leprosy has been removed and the patients have access to the services of ophthalmologists, surgeons, physiotherapists, and general physicians.

The most important step in eradication of any communicable disease is to knock out the last case. This can be achieved essentially by community participation for which vigorous IEC activities are required. It is only the enlightened public that can provide the solution to any social or public health problem.

With all the remarkable achievements in the fight against leprosy, the stage is now set for the final assault. It is hoped that the disease will be eradicated in the near future. The health authorities are highly capable and are fully armed, with political will that has sustained the NLEP all these years, India could well be leprosy-free.

   References Top

1.Joshi PL. National scenario, National Leprosy Eradication Programme and new paradigms. IAL text book of leprosy. New Delhi: Jaypee Brothers Medical Publishers; 2010. p. 35-43.  Back to cited text no. 1
2.NLEP -Progress report for of the Year 2010-11. New Delhi: Central Leprosy Division, Directorate General of Health Services; 2011. p. 1-4.  Back to cited text no. 2
3.Narain JP, Dash AP, Parnell B, Bhattacharya SK, Barua S, Bhatia R, et al. Elimination of neglected tropical diseases in the South-East Asia Region of the World Health Organization. Bull World Health Organ 2010; 88 : 206-10.  Back to cited text no. 3
4.Regional strategy for sustaining leprosy services and further reduction in burden of leprosy 2006-2010. WHO Project ICP CPC 600. New Delhi: WHO Regional Office for South-East Asia; 2005. p. 1-16.   Back to cited text no. 4
5.Shetty VP. Challenges facing the control of leprosy in the Indian context. Ann Acad Med 2010; 39 : 1-3.  Back to cited text no. 5

This article has been cited by
1 Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India
Niranjan Prakash Mahajan,Mallika Lavania,Itu Singh,Saraswati Nashi,Veeramani Preethish-Kumar,Seena Vengalil,Kiran Polavarapu,Chevula Pradeep-Chandra-Reddy,Muddasu Keerthipriya,Anita Mahadevan,Tagaduru Chickabasaviah Yasha,Bevinahalli Nanjegowda Nandeesh,Krishnamurthy Gnanakumar,Gareth J. Parry,Utpal Sengupta,Atchayaram Nalini
The American Journal of Tropical Medicine and Hygiene. 2020; 102(3): 547
[Pubmed] | [DOI]
2 Appropriately Selected Nerve in Suspected Leprous Neuropathy Yields High Positive Results for Mycobacterium leprae DNA by Polymerase Chain Reaction Method
Seena Vengalil,Mallika Lavania,Itu Singh,Saraswati Nashi,Veeramani Preethish-Kumar,Kiran Polavarapu,Niranjan Prakash Mahajan,Sanita Raju,Chevula Pradeep-Chandra-Reddy,Muddasu Keerthipriya,Anita Mahadevan,Tagadur Chickabasaviah Yasha,Bevinahalli Nandeesh,Krishnamurthy Gnanakumar,Gareth J. Parry,Utpal Sengupta,Atchayaram Nalini
The American Journal of Tropical Medicine and Hygiene. 2020; 103(1): 209
[Pubmed] | [DOI]
3 Wanda Blenska and the program of leprosy treatment in Uganda
Agnieszka Polak,Edyta Chomentowska,Agnieszka Rolinska,Andrzej Grzybowski
Clinics in Dermatology. 2019;
[Pubmed] | [DOI]
4 Resistance to anti leprosy drugs in multi-bacillary leprosy: A cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India
SatyendraKumar Singh,Ajit Kumar,Gopal Nath,TejBali Singh,MuktiNath Mishra
Indian Journal of Dermatology, Venereology and Leprology. 2018; 84(3): 275
[Pubmed] | [DOI]
5 Pitfalls in the diagnosis of leprous neuropathy: Lessons learnt from a University hospital in an endemic zone
Madhu Nagappa,Yasha T. Chickabasaviah,Anita Mahadevan,Raja Parthiban,Arun B. Taly
Journal of the Neurological Sciences. 2015; 357(1-2): 252
[Pubmed] | [DOI]
6 Computational Modelling of Dapsone Interaction With Dihydropteroate Synthase inMycobacterium leprae; Insights Into Molecular Basis of Dapsone Resistance in Leprosy
Sundeep Chaitanya,Madhusmita Das,Pritesh Bhat,Mannam Ebenezer
Journal of Cellular Biochemistry. 2015; 116(10): 2293
[Pubmed] | [DOI]
7 Advancing Sino-Indian Cooperation to Combat Tropical Diseases
Peter Hotez,Sunit K. Singh,Xiao-Nong Zhou
PLoS Neglected Tropical Diseases. 2013; 7(9): e2204
[Pubmed] | [DOI]
8 The eradication of leprosy: molecular modeling techniques for novel drug discovery
Shanmugam Anusuya,Jeyakumar Natarajan
Expert Opinion on Drug Discovery. 2013; 8(10): 1239
[Pubmed] | [DOI]
9 Worldwide elimination of leprosy: historical journey from the past to the future
PSS Sundar Rao
Expert Review of Dermatology. 2012; 7(6): 513
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded418    
    Comments [Add]    
    Cited by others 9    

Recommend this journal